{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:28:38Z","timestamp":1768015718990,"version":"3.49.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Extramedullary infiltration (EMI) is a rare condition defined by the accumulation of myeloid tumor cells beyond the bone marrow. The clinical significance is still controversial. This study was aimed to evaluate the incidence, characteristics, and prognostic significance of EMI on complete magnetic resonance imaging (MRI) investigation in newly diagnosed pediatric acute myeloid leukemia (AML) patients who are asymptomatic without clinical evidence to suspect EMI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>Retrospective clinical and radiologic review of 121 patients with MRI examination at the time of initial diagnosis of AML without any clinical evidence suggestive of EMI was performed. Patients were divided into 2 groups according to the presence or absence of EMI, and the relationship between EMI and established risk factors was analyzed. Initial white blood cell count, the occurrence of an event (including relapse, death, and primary refractory disease), survival status, and detailed information on cytogenetic\/molecular status was performed by a thorough review of electronic medical records system. All patients underwent full imaging evaluation with the contrast-enhanced whole body and some regional MRI at the time of initial diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The median age at diagnosis was 10.77 years (range, 0.37 to 18.83\u2009y). Based on the risk stratification system of AML, 36, 45, and 40 patients are classified as low-risk, intermediate-risk, and high-risk groups, respectively. MRI at the time of the initial diagnosis of AML revealed 35 of 121 patients (28.9%) with EMI. The most common site of EMI was a skull, followed by the lower extremity bone and meninges of the brain. The median age at diagnosis was significantly younger in patients with EMI (7.87 vs. 11.08\u2009y, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0212). Low incidence of <jats:italic toggle=\"yes\">FLT3\/ITD<\/jats:italic> mutation, low incidence of <jats:italic toggle=\"yes\">AML-ETO<\/jats:italic> gene rearrangement, and the larger extent and more severe degree of bone marrow involvement was related with EMI. However, there was no significant prognostic difference in event-free survival and overall survival regardless of the presence of EMI in the overall patient population and each risk group. The location of EMI occurrence was also not related to prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Even if EMI symptoms are not evident, surveillance MRI scans at the initial diagnosis of pediatric AML patients are very helpful in detecting a significant number of EMIs. Younger age, some molecular features, and more severe bone marrow involvement of AML patients were related with EMI. However, there was no significant prognostic difference between patients with or without EMI regardless of risk group. Further prospective investigation is necessary to validate the prognostic effect of EMI in a larger group of patients with different risk groups.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002353","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T02:04:09Z","timestamp":1634954649000},"page":"e713-e718","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Extramedullary Infiltration in Pediatric Acute Myeloid Leukemia on Surveillance Magnetic Resonance Imaging and its Relationship With Established Risk Factors"],"prefix":"10.1097","volume":"44","author":[{"given":"Eu Hyun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Radiology"},{"name":"Department of Radiology, St. Vincent\u2019s Hospital, College of Medicine, The Catholic University of Korea, Suwon-si, Gyeonggi-do Province, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Ah","family":"Im","sequence":"additional","affiliation":[{"name":"Department of Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongkoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1016\/j.clml.2020.06.009","article-title":"Prognostic impact of extramedullary infiltration in pediatric low-risk acute myeloid leukemia: a retrospective single-center study over 10 years","volume":"20","author":"Hu","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jped.2015.08.008","article-title":"Acute myeloid leukemia: analysis of epidemiological profile and survival rate","volume":"92","author":"de Lima","year":"2016","journal-title":"J Pediatr (Rio J)"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jped.2020.02.003","article-title":"Epidemiological evaluation and survival of children with acute myeloid leukemia","volume":"97","author":"Morais","year":"2020","journal-title":"J Pediatr (Rio J)"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1634\/theoncologist.12-3-341","article-title":"Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia","volume":"12","author":"Meshinchi","year":"2007","journal-title":"Oncologist"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000497210","article-title":"Myeloid sarcoma","volume":"42","author":"Magdy","year":"2019","journal-title":"Oncol Res Treat"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"20160710","DOI":"10.1259\/bjr.20160710","article-title":"Unravelling chloroma: review of imaging findings","volume":"90","author":"Singh","year":"2017","journal-title":"Br J Radiol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00432-020-03128-7","article-title":"Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia","volume":"146","author":"Xu","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2016.04.001","article-title":"Extramedullary acute myelogenous leukemia","volume":"30","author":"Solh","year":"2016","journal-title":"Blood Rev"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5045\/br.2017.52.3.184","article-title":"Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience","volume":"52","author":"Lee","year":"2017","journal-title":"Blood Res"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pbc.20824","article-title":"Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia","volume":"48","author":"Kobayashi","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250804","first-page":"444","article-title":"Myeloid sarcoma in children\u2014diagnostic and therapeutic difficulties","volume":"20","author":"Samborska","year":"2016","journal-title":"Contemp Oncol (Pozn)"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00256-007-0308-4","article-title":"Magnetic resonance imaging of bone marrow in oncology, part 2","volume":"36","author":"Hwang","year":"2007","journal-title":"Skeletal Radiol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","volume":"120","author":"Creutzig","year":"2012","journal-title":"Blood"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sj.leu.2401971","article-title":"Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia","volume":"15","author":"Bisschop","year":"2001","journal-title":"Leukemia"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature","volume":"47","author":"Paydas","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocytic sarcoma","volume":"122","author":"Lan","year":"2009","journal-title":"Acta Haematol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/MPH.0000000000001623","article-title":"Prognostic role of postinduction minimal residual disease and myeloid sarcoma type extramedullary involvement in pediatric RUNX1-RUNX1T1 (+) acute myeloid leukemia","volume":"42","author":"Lee","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R20-20250804","first-page":"e1711","article-title":"Extramedullary relapse of acute myeloid and lymphoid leukemia in children: a retrospective analysis","volume":"26","author":"Kim","year":"2016","journal-title":"Iran J Pediatr"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clml.2017.02.004","article-title":"Whole body MR imaging: a useful imaging modality in the management of children with acute myeloid leukemia","volume":"17","author":"Yoon","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R22-20250804","first-page":"2802596","article-title":"The usefulness of T1-weighted magnetic resonance images for diagnosis of acute leukemia manifesting musculoskeletal symptoms prior to appearance of peripheral blood abnormalities","volume":"2016","author":"Yoshikawa","year":"2016","journal-title":"Case Rep Pediatr"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:12:59Z","timestamp":1754338379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002353","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"2021-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}